Maria C. Vladoiu

ORCID: 0000-0001-8644-0581
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Glioma Diagnosis and Treatment
  • Single-cell and spatial transcriptomics
  • Galectins and Cancer Biology
  • Cancer-related molecular mechanisms research
  • Epigenetics and DNA Methylation
  • Glycosylation and Glycoproteins Research
  • Genomics and Chromatin Dynamics
  • Cancer Genomics and Diagnostics
  • Toxin Mechanisms and Immunotoxins
  • Chromatin Remodeling and Cancer
  • RNA modifications and cancer
  • RNA Research and Splicing
  • Hedgehog Signaling Pathway Studies
  • CAR-T cell therapy research
  • Circular RNAs in diseases
  • Spectroscopy Techniques in Biomedical and Chemical Research
  • MicroRNA in disease regulation
  • Spectroscopy and Chemometric Analyses
  • Neurogenesis and neuroplasticity mechanisms
  • Phytoplasmas and Hemiptera pathogens
  • interferon and immune responses
  • Hippo pathway signaling and YAP/TAZ
  • Fetal and Pediatric Neurological Disorders
  • Meningioma and schwannoma management
  • Immune cells in cancer

University of Toronto
2018-2025

Hospital for Sick Children
2017-2025

SickKids Foundation
2018-2025

McMaster University
2024

Centre Hospitalier de l’Université de Montréal
2018

McGill University
2017

Brain Tumour Research
2017

Institut National de la Recherche Scientifique
2014-2017

Montreal Neurological Institute and Hospital
2017

Cancer Institute (WIA)
2017

Liam D. Hendrikse Parthiv Haldipur Olivier Saulnier Jake Millman Alexandria H. Sjoboen and 95 more Anders W. Erickson Winnie Ong Victor Gordon Ludivine Coudière-Morrison Audrey Mercier Mohammad Shokouhian Raúl A. Suárez Michelle Ly Stephanie Borlase David S. Scott Maria C. Vladoiu Hamza Farooq Olga Sirbu Takuma Nakashima Shohei Nambu Yusuke Funakoshi Alec Bahcheli J. Javier Díaz-Mejía Joseph Golser Kathleen Bach Tram Phuong-Bao Patryk Skowron Evan Y. Wang Sachin Kumar Polina Balin Abhirami Visvanathan John J. Y. Lee Ramy Ayoub Xin Chen Xiaodi Chen Karen Mungall Betty Luu Pierre Bérubé Yu C. Wang Stefan M. Pfister Seung-Ki Kim Olivier Delattre Franck Bourdeaut François Doz Julien Masliah‐Planchon Wiesława Grajkowska James Loukides Peter B. Dirks Michelle Fèvre‐Montange Anne Jouvet Pim J. French Johan M. Kros Karel Zitterbart Swneke D. Bailey Charles G. Eberhart Amulya A. Nageswara Rao Caterina Giannini James M. Olson Miklós Garami Péter Hauser Joanna J. Phillips Stephanie Young Carmen de Torres Jaume Mora Kay K. W. Li Ho‐Keung Ng Wai Sang Poon Ian F. Pollack Enrique López‐Aguilar G. Yancey Gillespie Timothy Van Meter Tomoko Shofuda Rajeev Vibhakar Reid C. Thompson Michael K. Cooper Joshua B. Rubin Toshihiro Kumabe Shin Jung Bolesław Lach Achille Iolascon Veronica Ferrucci Pasqualino de Antonellis Massimo Zollo Giuseppe Cinalli Shenandoah Robinson Duncan Stearns Erwin G. Van Meir Paola Porrati Gaetano Finocchiaro Maura Massimino Carlos Gilberto Carlotti Cláudia C. Faria Martine F. Roussel Frederick A. Boop Jennifer A. Chan Kimberly A. Aldinger Ferechté Razavi Evelina Silvestri Roger E. McLendon Eric M. Thompson

10.1038/s41586-022-05215-w article EN Nature 2022-09-21

Abstract Existing RNA velocity estimation methods strongly rely on predefined dynamics and cell-agnostic constant transcriptional kinetic rates, assumptions often violated in complex heterogeneous single-cell sequencing (scRNA-seq) data. Using a graph convolution network, DeepVelo overcomes these limitations by generalizing to cell populations containing time-dependent kinetics multiple lineages. infers time-varying cellular rates of transcription, splicing, degradation, recovers each cell’s...

10.1186/s13059-023-03148-9 article EN cc-by Genome biology 2024-01-19

Targeting oncogenic pathways holds promise for brain tumor treatment, but inhibition of Sonic Hedgehog (SHH) signaling has failed in SHH-driven medulloblastoma. Cellular diversity within tumors and reduced lineage commitment can undermine targeted therapy by increasing the probability treatment-resistant populations. Using single-cell RNA-seq tracing, we analyzed cellular medulloblastomas transgenic, medulloblastoma-prone mice, responses to SHH-pathway inhibitor vismodegib. In untreated...

10.1038/s41467-019-13657-6 article EN cc-by Nature Communications 2019-12-20
Patryk Skowron Hamza Farooq Florence M.G. Cavalli A. Sorana Morrissy Michelle Ly and 94 more Liam D. Hendrikse Evan Y. Wang Haig Djambazian Helen Zhu Karen Mungall Quang M. Trinh Tina Zheng Shizhong Dai Ana Guerreiro Stücklin Maria C. Vladoiu Vernon Fong Borja Holgado Carolina Nör Xiaochong Wu Diala Abd-Rabbo Pierre Bérubé Yu Chang Wang Betty Luu Raúl A. Suárez Avesta Rastan Aaron H. Gillmor John J. Y. Lee Xiaoyun Zhang Craig Daniels Peter B. Dirks David Malkin Éric Bouffet Uri Tabori James Loukides François Doz Franck Bourdeaut Olivier Delattre Julien Masliah‐Planchon Olivier Ayrault Seung-Ki Kim David Meyronet Wiesława Grajkowska Carlos Gilberto Carlotti Carmen de Torres Jaume Mora Charles G. Eberhart Erwin G. Van Meir Toshihiro Kumabe Pim J. French Johan M. Kros Nada Jabado Bolesław Lach Ian F. Pollack Ronald L. Hamilton Amulya A. Nageswara Rao Caterina Giannini James M. Olson László Bognár Álmos Klekner Karel Zitterbart Joanna J. Phillips Reid C. Thompson Michael K. Cooper Joshua B. Rubin Linda M. Liau Miklós Garami Péter Hauser Kay Ka Wai Li Ho‐Keung Ng Wai Sang Poon G. Yancey Gillespie Jennifer A. Chan Shin Jung Roger E. McLendon Eric M. Thompson David Zagzag Rajeev Vibhakar Young Seob Shin Maria Luisa Garrè Ulrich Schüller Tomoko Shofuda Cláudia C. Faria Enrique López‐Aguilar Gelareh Zadeh Chi‐chung Hui Vijay Ramaswamy Swneke D. Bailey Steven J.M. Jones Andrew J. Mungall Richard A. Moore John A. Calarco Lincoln Stein Gary D. Bader Jüri Reimand Jiannis Ragoussis William A. Weiss Marco A. Marra Hiromichi Suzuki Michael D. Taylor

Abstract Sonic hedgehog medulloblastoma encompasses a clinically and molecularly diverse group of cancers the developing central nervous system. Here, we use unbiased sequencing transcriptome across large cohort 250 tumors to reveal differences among molecular subtypes disease, demonstrate previously unappreciated importance non-coding RNA transcripts. We identify alterations within cAMP dependent pathway ( GNAS , PRKAR1A ) which converge on GLI2 activity show that 18% have genetic event...

10.1038/s41467-021-21883-0 article EN cc-by Nature Communications 2021-03-19

Abstract Many genes that drive normal cellular development also contribute to oncogenesis. Medulloblastoma (MB) tumors likely arise from neuronal progenitors in the cerebellum, and we hypothesized heterogeneity observed MBs with sonic hedgehog (SHH) activation could be due differences developmental pathways. To investigate this question, here perform single-nucleus RNA sequencing on highly differentiated SHH extensively nodular histology malignant cells resembling each stage of canonical...

10.1038/s41467-023-44300-0 article EN cc-by Nature Communications 2024-01-08

Objective To test if Raman spectroscopy ( RS ) is an appropriate tool for the diagnosis and possibly grading of prostate cancer PC a). Patients Methods Between 20 50 spectra were acquired from 32 fresh non‐processed post‐prostatectomy specimens using a macroscopic handheld probe. Each measured area was characterized categorized according to histopathological criteria: tissue type (extraprostatic or prostatic); malignancy (benign malignant); grade (Grade Groups [ GG s] 1–5); glandular level....

10.1111/bju.14199 article EN BJU International 2018-03-15

Medulloblastoma (MB) is a neoplasm linked to dysregulated cerebellar development. Previously, we demonstrated that the Sonic Hedgehog (SHH) subgroup grows hierarchically, with Sox2+ cells at apex of tumor progression and relapse. To test whether this mechanism rooted in normal developmental process, studied role Sox2 We find external germinal layer (EGL) derived from embryonic precursors EGL maintains rare fraction during first postnatal week. Through lineage tracing single-cell analysis,...

10.1016/j.celrep.2020.03.075 article EN cc-by-nc-nd Cell Reports 2020-04-01

Human cerebral cancers are known to contain cell types resembling the varying stages of neural development. However, basis this association remains unclear. Here, we map development mouse cerebrum across developmental time-course, from embryonic day 12.5 postnatal 365, performing single-cell transcriptomics on >100,000 cells. By comparing reference atlas data >100 glial tumours adult and paediatric human cerebrum, find that tumour cells have an expression signature overlaps with temporally...

10.1038/s41467-022-31408-y article EN cc-by Nature Communications 2022-07-19

// Andrée-Anne Grosset 1, 2 , Marilyne Labrie 1 Maria Claudia Vladoiu Einas M Yousef Louis Gaboury Yves St-Pierre INRS-Institut Armand-Frappier, Laval, Quebec H7V 1B7, Canada IRIC | Université de Montréal, Montreal, H3T 1J4, Correspondence to: St-Pierre, e-mail: yves.st-pierre@iaf.inrs.ca Keywords: breast cancer, triple negative, galectins, tissue microarrays, immunohistochemistry Received: November 05, 2015 Accepted: January 29, 2016 Published: February 27, ABSTRACT Because of their ability...

10.18632/oncotarget.7784 article EN Oncotarget 2016-02-27

// Marilyne Labrie 1 , Maria Claudia Vladoiu Andrée-Anne Grosset Louis Gaboury 2 and Yves St-Pierre INRS-Institut Armand-Frappier, Laval, Québec, Canada Institute for Research in Immunology Cancer, Downtown Station, Montréal, Correspondence: St-Pierre, email: Keywords : galectin-7, ovarian cancer, immunosupression, p53, MMP-9 Received June 09, 2014 Accepted July 31, Published Abstract There is a critical need to develop effective new strategies diagnosis treatment of cancer. In the present...

10.18632/oncotarget.2299 article EN Oncotarget 2014-07-31

Abstract OTX2 is a potent oncogene that promotes tumor growth in Group 3 medulloblastoma. However, the mechanisms by which represses neural differentiation are not well characterized. Here, we perform extensive multiomic analyses to identify an regulatory network controls medulloblastoma cell fate. silencing modulates repressive chromatin landscape, decreases levels of PRC2 complex genes and increases expression neurodevelopmental transcription factors including PAX3 PAX6 . Expression...

10.1038/s41467-020-17357-4 article EN cc-by Nature Communications 2020-07-20

Galectins are small soluble lectins that bind α-galactosides via their carbohydrate recognition domain (CRD). Their ability to dimerize is critical for the crosslinking of glycoprotein receptors and subsequent cellular signaling. This particularly important in immunomodulatory role induction T-cell apoptosis. Because galectins play a central many pathologies, including cancer, they represent valuable therapeutic targets. At present, most inhibitors have been directed towards CRD, challenging...

10.18632/oncotarget.5403 article EN Oncotarget 2015-10-01

The observation that galectin-7 (gal-7) is specifically expressed in mammary myoepithelial (basal) cells prompted us to investigate whether this protein the basal of other tissues. Given breast and prostate cancer have remarkable underlying biological similarities given important roles cancer, we examined expression patterns role gal-7 human cancer. Using tissue microarray, found although readily normal tissue, it downregulated (PCa) cells. De novo increases their sensitivity apoptosis...

10.1371/journal.pone.0131307 article EN cc-by PLoS ONE 2015-07-13

Summary The study of the origin and development cerebellar tumours has been hampered by complexity heterogeneity cells that change over course development. We used single-cell transcriptomics to >60,000 from developing murine cerebellum, show different molecular subgroups childhood tumors mirror transcription distinct, temporally restricted lineages. Sonic Hedgehog medulloblastoma transcriptionally mirrors granule cell hierarchy as expected, whereas Group 3 resemble Nestin +ve stem cells,...

10.1101/350280 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2018-06-19
Coming Soon ...